Skip to content

Withdraw due to duplicate registration; Improvement of skeletal and muscle health in patients with sarcopenia by AIBEN YUEDONG Protein Nutrition Powder in combination with a resistance exercise intervention

Improvement of skeletal and muscle health in patients with sarcopenia by AIBEN YUEDONG Protein Nutrition Powder in combination with a resistance exercise intervention

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113394
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-09-11
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Sponsors

Beijing Luhe Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for sarcopenia AWGS 2019 (i Grip strength less than 28.0 kg for males and less than 18.0 kg for females. ii 6-meter stride speed less than 1.0 m/s or 5-repetition sit-up test time >=12 seconds or SPPB <=9 points. iii BIA less than 7.0 kg/m^2 for males and 5.7 kg/m^2 for females or DXA less than 7.0 kg/m^2 for males and 5.4 kg/m^2 for females); 2. Age between 35-75 years old with high compliance; 3. Complete clinical data; 4. Voluntary participation in the program with informed consent and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1. A clear history of allergy to protein powder in the past 6 months, or the presence of diarrhea symptoms and the frequency of >= 7 days / month, the duration of more than 2 weeks; 2. Major physical diseases (diabetes with serious complications, malignant tumors, serious cardiovascular disease, neurological diseases or other diseases that may affect the effectiveness of exercise and nutritional interventions, etc.); 3. The past three months, new fractures and recently underwent joint replacement surgery patients; 4. Suffering from congenital bone or muscle diseases; 5. The simultaneous existence of other comorbidities affecting muscle metabolism, such as malignant tumors, liver disease, severe organ insufficiency such as nephrotic syndrome, renal failure and other diseases that may affect protein metabolism; 6. Participating in other clinical trials patients; 7. With sensory disabilities or other reasons significantly affecting the collection of data, such as severe deafness, blindness, mental disorders, etc. 8. The researchers The researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Physical fitness;Non handgrip strength;6-minute walk test;Blood biochemical indices associated with sarcopenia;Sit-to-stand test;Appendicular skeletal muscle mass index;

Secondary

MeasureTime frame
Serum-associated inflammatory factor;blood lipids;Daily living skills;Number of intestinal flora;weight;Degree of knee injury;General cognitive functioning;Sleep conditions;Knee joint structure and pathology;Height;fasting blood glucose;Intestinal flora species;Insulin;Body composition;Bone mineral density;Dietary intake status;Level of intestinal flora differentiation;

Countries

China

Contacts

Public ContactZhang Qin

Beijing Luhe Hospital Affiliated to Capital Medical University

624203013@qq.com+86 10 69578083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026